NCT00233480 Statin Therapy in Heart Failure: Potential Mechanisms of Benefit Status COMPLETED Phase PHASE4
NCT00232154 A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To Status COMPLETED Phase PHASE2
NCT00230568 EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) Status COMPLETED Phase PHASE4
NCT00229476 Study of Medication and Placebo Response in Major Depression Status COMPLETED Phase PHASE4
NCT00229242 Comparison of Diuretic-based With Non-diuretic Based Hypertension Therapy Using Echocardiographic Measures Status COMPLETED Phase NA
NCT00227240 Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis Status COMPLETED Phase N/A
NCT00227188 Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain. Status COMPLETED Phase N/A
NCT00226811 An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy Status COMPLETED Phase PHASE2
NCT00225121 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00224289 Effect of Age on Latanoprost 0.005% in Patients With Glaucoma Status COMPLETED Phase PHASE4
NCT00220974 Study to Assess if Internet-Based Tailored Advice Could Modify Behaviour to Improve Health Status COMPLETED Phase NA
NCT00220402 Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome Status COMPLETED Phase PHASE3
NCT00220389 Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase Status COMPLETED Phase PHASE2
NCT00220376 Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome Status COMPLETED Phase PHASE3
NCT00220363 A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome Status COMPLETED Phase PHASE3
NCT00219635 Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation Status COMPLETED Phase PHASE2/PHASE3
NCT00219622 A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE2